Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope

ConditionHigh Myopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorFuzhou Eye Hospital

About this trial

Implantable collamer lens (ICL) implantation is considered one of the most effective surgical treatments for high myopia. The procedure primarily involves adjusting the position of the ICL within the eye. However, precise calculation of the ICL optical power may cause the surgical light source to remain focused on the macular area during this process, potentially leading to iatrogenic light-induced damage. Theoretically, the combination of a 3D visualization surgical system and coaxial illumination technology can reduce the illumination intensity and decrease iatrogenic light damage. This study aims to compare the retinal physiological changes in patients undergoing ICL surgery through 3D visualization surgical system with coaxial illumination versus a traditional microscope with standard illumination.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical diagnosis of high myopic

Aged 18-40 years

Desire to improve their refractive status via ICL surgery

Relatively stable refractive error (change ≤ 0.50 D per year for two consecutive years)

Disqualifiers

Cataracts

Corneal diseases,

Glaucoma,

Nystagmus,

Trial design

Design model

Parallel

Treatments tested in this trial

  • 3D visualization system with coaxial illumination

    Procedure/Surgery

    operation through 3D visualization system with coaxial illumination

  • microscope with standard illumination

    Procedure/Surgery

    operation through microscope with standard illumination

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: 3D visualization systemExperimental treatment 1 intervention
Group B: MicroscopeActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

b-wave amplitude

Time frame
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op

Secondary outcomes

1

a-wave amplitude

Time frame
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
2

macular vessel density

Time frame
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
3

Uncorrected visual acuity

Time frame
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
4

Best-corrected visual acuity

Time frame
1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op

Other outcomes

1

Intraoperative illumination intensity

Time frame
surgery beginning
2

Surgical time

Time frame
Starting with the making of the surgical incision and ending with incision closure

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fuzhou Eye Hospital

Lead sponsor

Alcon Research

Collaborator

This trial is not recruiting at the moment. You can still explore other options: